Interacting Drugs |
Rifapentine vs Roflumilast |
Security Level |
 |
Mechanism |
Roflumilast: CYP3A4 Inducers (Strong) may decrease the serum concentration of Roflumilast. |
Management |
Roflumilast U.S. prescribing information recommends against combining strong CYP3A4 inducers with roflumilast. The Canadian product monograph makes no such recommendation but notes that such agents may reduce roflumilast therapeutic effects. |
Rifapentine vs Roflumilast
Post Review about Rifapentine vs Roflumilast Click here to cancel reply.
Other Interactions of Rifapentine
Other Interactions of Roflumilast
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.